WATERTOWN, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (HOWL), an innovative biopharmaceutical company pioneering the development of novel, conditionally activated INDUKINE™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results